We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Combination Gives ‘Exciting’ Results in Ovarian & Lung Cancer in Early Trial

News   Aug 22, 2018 | Original story from the Institute of Cancer Research

 
Drug Combination Gives ‘Exciting’ Results in Ovarian & Lung Cancer in Early Trial
 
 
 

RELATED ARTICLES

AI Could Warn About Drug Interaction Side Effects

News

Researchers have designed an algorithm that analyzes data on drug-drug interactions listed in reports — compiled by the Food and Drug Administration and other organizations — for use in a possible alert system that would let patients know when a drug combination could prompt dangerous side effects.

READ MORE

Hormone Therapy Battles Cognitive Decline

News

A new study has identified benefits of extended estrogen exposure and longer-term hormone therapy in combating cognitive decline

READ MORE

Collaboration Fuels Hunt for New “Orphan Disease” Treatments

News

The National Institutes of Health has awarded a Michigan State University researcher a $2.1 million, five-year grant to search vast databases of existing drugs in the hope that some could be adapted to treat orphan diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE